Home › Crohn's Disease › South Carolina › North Charleston
Crohn's Disease clinical trials in North Charleston, SC
4 studies for Crohn's Disease are looking for participants at sites in and around North Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville · 16 mi away
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Palmetto Primary and Specialty Care Physicians, Charleston, Summerville · 16 mi away
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2
- Palmetto Gastroenterology Clinical Research, Summerville · 16 mi away
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
RecruitingPhase 3
- Medical University of South Carolina, North Charleston
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Tyler, TX17 studies
- Houston, TX17 studies
- Orlando, FL17 studies
- Atlanta, GA17 studies
- San Antonio, TX15 studies
- San Diego, CA15 studies
- Los Angeles, CA15 studies
Other studies in North Charleston
- Obesity11 studies
- Overweight6 studies
- Type 2 Diabetes5 studies
- Non-Muscle Invasive Bladder Cancer3 studies
- Heart Failure3 studies
- Attention Deficit Hyperactivity Disorder3 studies
- Hyperuricemia3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.